ArticleChemical science2026
Nickel-catalyzed asymmetric hydrogenation of α,β-unsaturated ester phosphonates.
Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chiral α-substituted β-functionalized phosphonates are valuable motifs in bioactive molecules, yet their direct catalytic asymmetric synthesis from α,β-unsaturated ester phosphonates remains underdeveloped. These substrates combine a highly electron-deficient alkene with two strongly coordinating polar groups, features that have largely confined their asymmetric hydrogenation to noble-metal catalysis. Here an efficient and highly enantioselective nickel-catalyzed hydrogenation of α,β-unsaturated ester phosphonates is reported. This reaction delivers chiral α-substituted ester phosphonates in up to 99% yield and 99% ee (enantiomeric excess) and operates at a high substrate-to-catalyst ratio (S/C) of 1000, significantly exceeding the S/C values of approximately 100 typical of noble-metal catalysts. The chiral products serve as versatile building blocks for synthesizing bioactive molecules such as glutamic acid phosphonate analogues, fosmidomycin derivatives, and β-aminophosphonic acid derivatives. DFT (density functional theory) calculations reveal that weak attractive noncovalent interactions between the catalyst and substrate stabilize the key transition state, which is crucial for the excellent enantioselectivity and activity. Furthermore, combined experimental and computational studies demonstrate that the regioselectivity is primarily determined by the kinetic preference of Ni-H migratory insertion, in which steric effects at the transition state play an important role.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.